Conference Correspondent

New Results with Existing Agents

ASCO 2014 – Lung Cancer, ASCO

Conference Correspondent — May 31, 2014

New Molecular Targets for NSCLC

ASCO 2014 – Lung Cancer, ASCO

Conference Correspondent — May 31, 2014

Immune Checkpoint Therapy in NSCLC

ASCO 2014 – Lung Cancer, ASCO

Conference Correspondent — May 31, 2014

Rechallenge with Anti-EGFR Therapy

ASCO 2014 – Colorectal and Head & Neck Cancer, ASCO

Conference Correspondent — May 31, 2014

BRAF + MEK Inhibitors in mCRC

ASCO 2014 – Colorectal and Head & Neck Cancer, ASCO

Conference Correspondent — May 31, 2014

BRAF Inhibitor + Cetuximab in mCRC

ASCO 2014 – Colorectal and Head & Neck Cancer, ASCO

Conference Correspondent — May 31, 2014

Second-Line Therapies in KRAS–Wild-Type mCRC

ASCO 2014 – Colorectal and Head & Neck Cancer, ASCO

Conference Correspondent — May 31, 2014

A New Predictive Biomarker for Cetuximab—The New EPOC Trial

ASCO 2014 – Colorectal and Head & Neck Cancer, ASCO

Conference Correspondent — May 31, 2014

Prophylactic Cranial Irradiation in the Adjuvant Setting in NSCLC

ASCO 2014 – Lung Cancer, ASCO

Conference Correspondent — May 31, 2014

Adjuvant Erlotinib in EGFR-Mutated NSCLC

ASCO 2014 – Lung Cancer, ASCO

Conference Correspondent — May 31, 2014

Page 43 of 44

40
41
42
43
44